Beth Hoffman
Fortuna: - $ al 30/06/2026
Fortuna: - $ al 30/06/2026
Beth J.
Hoffman is the founder of Origami Therapeutics, Inc., founded in 2015, where the title held is President & Chief Executive Officer.
Dr. Hoffman currently holds the position of Independent Director at Biofrontera, Inc., starting in 2015.
Dr. Hoffman earned a doctorate degree from The Johns Hopkins University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOFRONTERA, INC. -.--% | 04/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOFRONTERA INC. | Director/Miembro de la Junta | 03/03/2015 |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Director Ejecutivo | 01/01/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
| Empresas privadas | 3 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biofrontera, Inc.
Biofrontera, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes dermatological drugs | Health Technology |
Origami Therapeutics, Inc.
Origami Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical-stage biopharmaceutical company | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.